ClinicalTrials.Veeva
Menu

Find clinical trials for Adenocarcinoma in Birmingham, AL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma
Cancer
Pancreatic Cancer
Colorectal Cancer
Stomach Cancer
Esophageal Cancer
Non-Small-Cell Lung Carcinoma

Adenocarcinoma trials near Birmingham, AL, USA:

AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2

and safety of AZD0901 compared to Investigator's choice of therapy as 2L+ treatment for participants with advanced or metastatic gastric or GEJ adenocarcinoma...

Enrolling
Gastroesophageal Junction Cancer
Gastric Cancer
Drug: AZD0901
Drug: Docetaxel

Phase 3

AstraZeneca
AstraZeneca

Birmingham, Alabama, United States and 171 other locations

Barrett's Esophagus (BE), with or without dysplasia, and esophageal adenocarcinoma (EAC) as compared to Esophagogastroduodenoscopy (EGD) plu...

Enrolling
Esophageal Adenocarcinoma
Barretts Esophagus With Dysplasia
Diagnostic Test: Esophagogastroduodenoscopy
Device: EsoGuard (lab assay)
Lucid Diagnostics

Birmingham, Alabama, United States and 37 other locations

activity of ProAgio combined with gemcitabine and nab paclitaxel (G-nP) in previously untreated subjects with metastatic pancreatic ductal adenocarcinoma...

Enrolling
Pancreatic Ductal Carcinoma
Drug: ProAgio Dose Levels (DL) 1,2,3,4
Drug: Gemcitabine, nab paclitaxel

Phase 1

ProDa BioTech

Birmingham, Alabama, United States

The purpose of this study is to look at the efficacy and safety of Irinotecan liposome injection in combination with other approved drugs used for ca...

Active, not recruiting
Metastatic Adenocarcinoma of the Pancreas
Drug: Leucovorin
Drug: Gemcitabine

Phase 3

Ipsen
Ipsen

Birmingham, Alabama, United States and 199 other locations

This is a first-in-human, open-label, multi-center, Phase 1, dose-escalation study with expansion cohorts to evaluate NM32-2668 for safety and immuno...

Enrolling
Adenocarcinoma - Gastroesophageal Junction (GEJ)
Adenocarcinoma of the Stomach
Biological: NM32-2668

Phase 1

Numab Therapeutics

Birmingham, Alabama, United States and 7 other locations

* To evaluate the safety and tolerability of escalating doses of ERAS-007 in combination with other cancer therapies in study participants with advan...

Active, not recruiting
Metastatic Pancreatic Ductal Adenocarcinoma
Metastatic Colorectal Cancer
Drug: Cetuximab
Drug: ERAS-007

Phase 1, Phase 2

Erasca

Birmingham, Alabama, United States and 13 other locations

Locations recently updated

This is a randomized, phase 1b study to assess the safety, tolerability, pharmacokinetics (PK), and efficacy of sovilnesib at different dose levels t...

Enrolling
High Grade Serous Adenocarcinoma of Ovary
Primary Peritoneal Carcinoma
Drug: Sovilnesib

Phase 1

Volastra Therapeutics

Birmingham, Alabama, United States and 12 other locations

The main purpose of the study is to assess whether the study drug, LY4066434, is safe and tolerable when administered to participants with locally ad...

Enrolling
Pancreatic Ductal Adenocarcinoma
Advanced Solid Tumor
Drug: Pembrolizumab
Drug: Irinotecan

Phase 1

Lilly
Lilly

Birmingham, Alabama, United States and 23 other locations

This is a first-in-human Phase 1 clinical trial designed to investigate the safety, tolerability, pharmacokinetics, and biodistribution of \[225Ac\]-...

Enrolling
Pancreatic Ductal Adenocarcinoma (PDAC)
NTSR1 Expressing Solid Tumours
Drug: [111In]-FPI-2058
Drug: [225]-FPI-2059

Phase 1

Fusion Pharmaceuticals

Birmingham, Alabama, United States and 7 other locations

This phase III trial studies olaparib or cediranib maleate and olaparib to see how well they work compared with standard platinum-based chemotherapy...

Active, not recruiting
Ovarian Clear Cell Adenocarcinoma
Fallopian Tube Clear Cell Adenocarcinoma
Drug: Gemcitabine
Drug: Cediranib Maleate

Phase 3

National Cancer Institute (NCI)
National Cancer Institute (NCI)

Birmingham, Alabama, United States and 358 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems